A detailed history of Two Sigma Securities, LLC transactions in Cel Sci Corp stock. As of the latest transaction made, Two Sigma Securities, LLC holds 11,570 shares of CVM stock, worth $12,611. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,570
Holding current value
$12,611
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$1.63 - $3.08 $18,859 - $35,635
11,570 New
11,570 $22,000
Q3 2023

Nov 14, 2023

BUY
$1.17 - $2.86 $23,364 - $57,114
19,970 New
19,970 $24,000

Others Institutions Holding CVM

About CEL SCI CORP


  • Ticker CVM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,367,500
  • Market Cap $47.3M
  • Description
  • CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...
More about CVM
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.